Use in Pregnancy: The prophylactic treatment with Clamentin may be associated with an increased risk of necrotising enterocolitis in neonates. As with all medicines, use should be avoided in pregnancy, especially during the first trimester, unless considered essential by the physician.
Use in Lactation: Clamentin may be administered during the period of lactation. With the exception of the risk of sensitisation associated with the excretion of trace quantities in breast milk, there are no detrimental effects for the breast-fed infant.